Company press release: January 2008
Agion Technologies announced the company has secured additional regulatory approvals for specific formulations from government agencies in the U.S. and Switzerland.
The Environmental Protection Agency (EPA) has granted approval for the Agion formulation for use in medical devices, equipment, and supplies. This clears the path for the Agion antimicrobial technology to be incorporated directly into various materials including plastics, fibers, coatings, films, and laminates for use in the healthcare industry. The EPA registration for this market will enable additional manufacturers to incorporate Agion’s antimicrobial technology into their end products. Agion, Nature’s Antimicrobial, has recently been published to the International Cosmetic Ingredient Dictionary and Handbook as maintained by the Personal Care Products Council (PCPC), clearing the way for the expansion of Agion technology for use in consumer cosmetic, toiletry, and fragrance applications in the United States, Europe and Asia.
Agion has also received two additional National Sanitation Foundation (NSF) Standard 51 certifications for food processing and food service equipment materials. Agion’s partners hold NSF Standard 42 certifications, and Agion maintains EPA, FDA, (Food & Drug Administration), and USDA approvals for different formulations for use in food and water touch applications.
Additionally, Agion has announced that approval has been obtained for indirect food contact by the European Food Safety Authority (EFSA). This approval opens the door for further development in Europe of Agion-protected antimicrobial products for food packaging, preparation, and storage. Already a well known brand in the food industry in the United States, Agion continues to expand with additional regulatory approvals worldwide.
Agion, a global leader in antimicrobial solutions, continues to maintain regulatory approvals for different formulations from the EPA, FDA, EFSA, and NSF and is notified under the European BPD (Biocidal Products Directive) in addition to various other approvals and recognition in Europe, Asia, Canada, and Latin America.